Literature DB >> 33574239

GWAS for autoimmune Addison's disease identifies multiple risk loci and highlights AIRE in disease susceptibility.

Daniel Eriksson1,2,3, Ellen Christine Røyrvik4,5, Maribel Aranda-Guillén1, Amund Holte Berger4,5,6, Nils Landegren1,7, Haydee Artaza4,5, Åsa Hallgren1, Marianne Aardal Grytaas4,8, Sara Ström9,10, Eirik Bratland4,5,6, Ileana Ruxandra Botusan9,10, Bergithe Eikeland Oftedal4,5, Lars Breivik4,8, Marc Vaudel11, Øyvind Helgeland11,12, Alberto Falorni13, Anders Palmstrøm Jørgensen14, Anna-Lena Hulting10, Johan Svartberg15,16, Olov Ekwall17,18, Kristian Johan Fougner19, Jeanette Wahlberg20,21, Bjørn Gunnar Nedrebø4,22, Per Dahlqvist23, Per Morten Knappskog4,5,6, Anette Susanne Bøe Wolff4,5, Sophie Bensing9,10, Stefan Johansson4,6, Olle Kämpe24,25,26,27, Eystein Sverre Husebye28,29,30,31.   

Abstract

Autoimmune Addison's disease (AAD) is characterized by the autoimmune destruction of the adrenal cortex. Low prevalence and complex inheritance have long hindered successful genetic studies. We here report the first genome-wide association study on AAD, which identifies nine independent risk loci (P < 5 × 10-8). In addition to loci implicated in lymphocyte function and development shared with other autoimmune diseases such as HLA, BACH2, PTPN22 and CTLA4, we associate two protein-coding alterations in Autoimmune Regulator (AIRE) with AAD. The strongest, p.R471C (rs74203920, OR = 3.4 (2.7-4.3), P = 9.0 × 10-25) introduces an additional cysteine residue in the zinc-finger motif of the second PHD domain of the AIRE protein. This unbiased elucidation of the genetic contribution to development of AAD points to the importance of central immunological tolerance, and explains 35-41% of heritability (h2).

Entities:  

Year:  2021        PMID: 33574239     DOI: 10.1038/s41467-021-21015-8

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  68 in total

1.  Multiple loci in the HLA complex are associated with Addison's disease.

Authors:  Beate Skinningsrud; Benedicte A Lie; Ewa Lavant; Joyce A Carlson; Henry Erlich; Hanne E Akselsen; Kristina Gervin; Anette B Wolff; Martina M Erichsen; Kristian Løvås; Eystein S Husebye; Dag E Undlien
Journal:  J Clin Endocrinol Metab       Date:  2011-08-03       Impact factor: 5.958

2.  Autoimmune Polyendocrine Syndromes.

Authors:  Eystein S Husebye; Mark S Anderson; Olle Kämpe
Journal:  N Engl J Med       Date:  2018-06-28       Impact factor: 91.245

3.  INCREASING PREVALENCE OF ADDISON DISEASE: RESULTS FROM A NATIONWIDE STUDY.

Authors:  Andri Snaer Olafsson; Helga Agusta Sigurjonsdottir
Journal:  Endocr Pract       Date:  2015-10-05       Impact factor: 3.443

4.  Epidemiologic study of adrenal gland disorders in Japan.

Authors:  R Takayanagi; K Miura; H Nakagawa; H Nawata
Journal:  Biomed Pharmacother       Date:  2000-06       Impact factor: 6.529

5.  Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease.

Authors:  H Donner; J Braun; C Seidl; H Rau; R Finke; M Ventz; P G Walfish; K H Usadel; K Badenhoop
Journal:  J Clin Endocrinol Metab       Date:  1997-12       Impact factor: 5.958

6.  Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease.

Authors:  B Vaidya; H Imrie; D R Geatch; P Perros; S G Ball; P H Baylis; D Carr; S J Hurel; R A James; W F Kelly; E H Kemp; E T Young; A P Weetman; P Kendall-Taylor; S H Pearce
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

7.  Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features.

Authors:  Anne Grethe Myhre; Dag E Undlien; Kristian Løvås; Sverre Uhlving; Bjørn G Nedrebø; Kristian J Fougner; Thor Trovik; Jan I Sørheim; Eystein S Husebye
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

8.  21-Hydroxylase, a major autoantigen in idiopathic Addison's disease.

Authors:  O Winqvist; F A Karlsson; O Kämpe
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

Review 9.  Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency.

Authors:  E S Husebye; B Allolio; W Arlt; K Badenhoop; S Bensing; C Betterle; A Falorni; E H Gan; A-L Hulting; A Kasperlik-Zaluska; O Kämpe; K Løvås; G Meyer; S H Pearce
Journal:  J Intern Med       Date:  2013-12-16       Impact factor: 8.989

10.  Heritability of Addison's disease and prevalence of associated autoimmunity in a cohort of 112,100 Swedish twins.

Authors:  Jakob Skov; Jonas Höijer; Patrik K E Magnusson; Jonas F Ludvigsson; Olle Kämpe; Sophie Bensing
Journal:  Endocrine       Date:  2017-10-16       Impact factor: 3.633

View more
  12 in total

Review 1.  Genetic overlap between type 1 diabetes and other autoimmune diseases.

Authors:  Ana Márquez; Javier Martín
Journal:  Semin Immunopathol       Date:  2021-10-01       Impact factor: 9.623

Review 2.  Infections in the monogenic autoimmune syndrome APECED.

Authors:  Vasileios Oikonomou; Timothy J Break; Sarah L Gaffen; Niki M Moutsopoulos; Michail S Lionakis
Journal:  Curr Opin Immunol       Date:  2021-08-18       Impact factor: 7.268

3.  Thymic epithelial cells co-opt lineage-defining transcription factors to eliminate autoreactive T cells.

Authors:  Daniel A Michelson; Koji Hase; Tsuneyasu Kaisho; Christophe Benoist; Diane Mathis
Journal:  Cell       Date:  2022-06-16       Impact factor: 66.850

Review 4.  The genetics of autoimmune Addison disease: past, present and future.

Authors:  Ellen C Røyrvik; Eystein S Husebye
Journal:  Nat Rev Endocrinol       Date:  2022-04-11       Impact factor: 47.564

5.  The natural history of 21-hydroxylase autoantibodies in autoimmune Addison's disease.

Authors:  Anette Boe Wolff; Lars Breivik; Karl Ove Hufthammer; Marianne Aardal Grytaas; Eirik Bratland; Eystein Sverre Husebye; Bergithe Eikeland Oftedal
Journal:  Eur J Endocrinol       Date:  2021-04       Impact factor: 6.664

Review 6.  Latent Adrenal Insufficiency: From Concept to Diagnosis.

Authors:  Nada Younes; Isabelle Bourdeau; Andre Lacroix
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-27       Impact factor: 5.555

7.  Genome-wide association study identifies five risk loci for pernicious anemia.

Authors:  Triin Laisk; Maarja Lepamets; Mariann Koel; Erik Abner; Reedik Mägi
Journal:  Nat Commun       Date:  2021-06-18       Impact factor: 14.919

8.  Mechanistic dissection of dominant AIRE mutations in mouse models reveals AIRE autoregulation.

Authors:  Eystein S Husebye; Jakub Abramson; Yael Goldfarb; Tal Givony; Noam Kadouri; Jan Dobeš; Cristina Peligero-Cruz; Itay Zalayat; Golda Damari; Bareket Dassa; Shifra Ben-Dor; Yael Gruper; Bergithe E Oftedal; Eirik Bratland; Martina M Erichsen; Amund Berger; Ayelet Avin; Shir Nevo; Uku Haljasorg; Yael Kuperman; Adi Ulman; Rebecca Haffner-Krausz; Ziv Porat; Ulus Atasoy; Dena Leshkowitz
Journal:  J Exp Med       Date:  2021-09-03       Impact factor: 14.307

9.  21-Hydroxylase-Specific CD8+ T Cells in Autoimmune Addison's Disease Are Restricted by HLA-A2 and HLA-C7 Molecules.

Authors:  Alexander Hellesen; Sigrid Aslaksen; Lars Breivik; Ellen Christine Røyrvik; Øyvind Bruserud; Kine Edvardsen; Karl Albert Brokstad; Anette Susanne Bøe Wolff; Eystein Sverre Husebye; Eirik Bratland
Journal:  Front Immunol       Date:  2021-10-14       Impact factor: 7.561

10.  Primary Ovarian Insufficiency in Women With Addison's Disease.

Authors:  Elinor C Vogt; Lars Breivik; Ellen C Røyrvik; Marianne Grytaas; Eystein S Husebye; Marianne Øksnes
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.